Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Sarcoma 12Osteosarcoma 9Rhabdomyosarcoma 7Neuroblastoma 7Wilms Tumor 6Rhabdoid Tumor 6Lymphoma, Non-Hodgkin 6Hepatoblastoma 6Sarcoma, Ewing 5Neuroectodermal Tumors, Primitive, Peripheral 5Medulloblastoma 5Histiocytosis, Langerhans-Cell 5Glioma 5Ependymoma 5Central Nervous System Neoplasms 4Liposarcoma 3Carcinosarcoma 3Sarcoma, Synovial 2Ovarian Neoplasms 2Neurofibrosarcoma 2Melanoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Gliosarcoma 2Glioblastoma 2Endometrial Neoplasms 2Desmoid Tumors 2Carcinoma, Hepatocellular 2Xanthogranuloma, Juvenile 1Uterine Cervical Neoplasms 1

Interventions

AZD 6244 3X-Rays 1Surgical Procedures, Operative 1Specimen Handling 1Sirolimus 1Radiotherapy 1Photons 1Magnetic Resonance Spectroscopy 1Liquid Biopsy 1Ifosfamide 1High-Energy Shock Waves 1Filgrastim 1Etoposide 1Doxorubicin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibromatosis 1 × X-Rays × Sarcoma × Clear all
NCT02700230 2024-09-27

Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery

Mayo Clinic

Phase 1 Completed
9 enrolled
CNSSarcoma

Neurofibromatosis 1, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡